Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Adult ADHD News

ADHD Medication Use May Lower Mortality
News
ADHD Medication Use May Lower Mortality
04/09/2024
Evi Arthur
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in...
04/09/2024
Psych Congress Network
Adults With ADHD Report Camouflaging Their Symptoms
News
Adults With ADHD Report 'Camouflaging' Their Symptoms
04/01/2024
Jolynn Tumolo
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or...
04/01/2024
Psych Congress Network

Advertisement

DBT and CBT Adherence Important for Effective Adult ADHD Treatment
News
DBT and CBT Adherence Important for Effective Adult ADHD Treatment
03/13/2024
Evi Arthur
Adherence to cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) was found to maximize treatment efficiency for adults with attention-deficit/hyperactivity disorder (ADHD), according to recent results from a randomized...
Adherence to cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) was found to maximize treatment efficiency for adults with attention-deficit/hyperactivity disorder (ADHD), according to recent results from a randomized...
Adherence to cognitive...
03/13/2024
Psych Congress Network
Stimulant Treatment for ADHD Safe to Continue During Pregnancy
News
Stimulant Treatment for ADHD Safe to Continue During Pregnancy
03/04/2024
Evi Arthur
Amphetamine/dextroamphetamine and methylphenidate exposure in utero are unlikely to increase the risk of childhood neurodevelopmental disorders, according to a recent cohort study published in JAMA Psychiatry.
Amphetamine/dextroamphetamine and methylphenidate exposure in utero are unlikely to increase the risk of childhood neurodevelopmental disorders, according to a recent cohort study published in JAMA Psychiatry.
Amphetamine/dextroamphetamine...
03/04/2024
Psych Congress Network
Women With ADHD Diagnosed, On Average, 4 Years Later Than Men
News
Women With ADHD Diagnosed, On Average, 4 Years Later Than Men
02/08/2024
Evi Arthur
Women with ADHD are diagnosed, on average, 4 years later than their male counterparts and have a higher burden of comorbid psychiatric conditions, according to a study published in The Journal of Child Psychology and Psychiatry.
Women with ADHD are diagnosed, on average, 4 years later than their male counterparts and have a higher burden of comorbid psychiatric conditions, according to a study published in The Journal of Child Psychology and Psychiatry.
Women with ADHD are diagnosed,...
02/08/2024
Psych Congress Network

Advertisement

ADHD Medication Use Sharply Increased During COVID-19 Pandemic
News
ADHD Medication Use Sharply Increased During COVID-19 Pandemic
02/06/2024
Evi Arthur
Though use of many other behavioral health medications remained steady throughout the COVID-19 pandemic, use of medications for ADHD sharply increased, according to a cross-sectional study posted in JAMA Psychiatry.
Though use of many other behavioral health medications remained steady throughout the COVID-19 pandemic, use of medications for ADHD sharply increased, according to a cross-sectional study posted in JAMA Psychiatry.
Though use of many other...
02/06/2024
Psych Congress Network
a doctor holds a generic orange pill bottle
News
Zenzedi CII 30 mg Tablets Recalled Over Mislabeling Concerns
01/29/2024
Meagan Thistle
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has...
01/29/2024
Neurology
ADHD Drug Persistence Lower Than Expected in Teens, Young Adults
News
ADHD Drug Persistence Lower Than Expected
01/15/2024
Jolynn Tumolo
More than half of teens, young adults, and adults prescribed medication for attention-deficit/hyperactivity disorder (ADHD) stop taking it within the first year, according to a multinational study of more than 1.2 million patients published...
More than half of teens, young adults, and adults prescribed medication for attention-deficit/hyperactivity disorder (ADHD) stop taking it within the first year, according to a multinational study of more than 1.2 million patients published...
More than half of teens, young...
01/15/2024
Psych Congress Network

Advertisement

Long-term ADHD Med Use May Hike CVD Risk
News
Long-term ADHD Med Use May Hike CVD Risk
01/02/2024
Evi Arthur
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to...
01/02/2024
Psych Congress Network
Link Established Between Adult ADHD and Elevated Dementia Risk
News
Link Established Between Adult ADHD and Elevated Dementia Risk
12/01/2023
Evi Arthur
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open. 
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open. 
Adult...
12/01/2023
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use